Skip to main content

Table 6 Statements reaching consensus regarding themes 3 and 4

From: Cancer related fatigue: implementing guidelines for optimal management

Theme 3: Integrate CRF management with existing practices Survey N Agree (n) Agree (%)
 Fatigue management should be a part of routine cancer services C2 59 57 96.6
 Once clinicians identify moderate to severe fatigue they should seek advice and/or refer for comprehensive assessment HP2 32 31 96.9
 Ask me about my fatigue level during routine appointments C2 59 48 81.4
 A self-assessment for patient to identify issues would be time-efficient for clinicians HP2 32 26 81.3
 Applying standardised diagnostic criteria for CRF is useful in the clinical setting to distinguish CRF from other types of fatigue HP2 32 26 81.3
Theme 4: Consumer-focused care Survey N Agree (n) Agree (%)
 Essential time points for fatigue screening     
  At diagnosis HP2 32 24 75.0
  At diagnosis or start of treatment as baseline C2 59 48 81.4
  At end of a treatment course C2 59 52 88.1
  During routine assessment before each new treatment C2 59 52 88.1
  After hospitalisation or changed health status C2 59 51 86.4
  3 months post treatment C2 59 50 84.7
  At annual check up C2 59 48 81.4
 It is essential to be made aware of the possibility of fatigue and how to measure it, when you are first diagnosed with cancer C2 59 53 89.8
 Information and education about fatigue should be offered at different levels of detail (e.g. basic, standard, detailed) C2 59 53 89.8
 Access to individual or group education about fatigue supported by written material is important to me C2 59 53 89.8
 It is important to me to have some say in when, where and how I am assessed if I have moderate to severe fatigue C2 59 52 89.8
 I would like to be given the choice of doing a paper, electronic or verbal questionnaire to assess my fatigue C2 59 50 88.8
 I would prefer a longer appointment for fatigue assessment compared to extra visits C2 59 46 78.0
 More detailed information about fatigue prevention can come once treatment has started. C2 59 45 76.2
 One of the five most important factors that would encourage you (CS) to adopt the CAPO guideline: If my health professional promoted its use C1 32 24 75.0